About this trial
The aim of this study is to investigate whether whole-body cryotherapy (a brief exposure to very cold temperatures) can help reduce pain and improve quality of life in people living with endometriosis, and whether it may represent a safe, non-pharmacological approach to managing endometriosis-related symptoms.
Up to 30 participants with symptomatic endometriosis (chronic pelvic pain for more than six months) will be recruited over a 12-month period. Participants will attend two study visits at the hospital, approximately four weeks apart. Between these visits, participants will undergo five whole-body cryotherapy sessions, each lasting approximately 3 minutes. During cryotherapy, participants stand in a specialised chamber where the body is briefly exposed to cold, dry air (around -120°C).
During the study, will be assessed changes in systemic inflammation and biological markers using blood, saliva, urine, vaginal, and stool samples. Data will be collected using questionnaires evaluating pain and related symptoms, quality of life, sleep, fatigue, intestinal symptoms, and overall wellbeing.
The active study phase lasts approximately 4-6 weeks. A final follow-up assessment at 15 weeks will be conducted remotely using questionnaires and self-collected samples.
Eligibility criteria
Qualifiers
Women or assigned female at birth
Aged 16 or over
Endometriosis identified at laparoscopy or imaging, performed within the last ten years
Chronic pelvic pain for more than six months
Disqualifiers
Pregnant, breastfeeding or actively trying to get pregnant
Post-menopausal (no periods for >12 months and not taking hormonal treatments to prevent periods, or bilateral oophorectomy performed)
Previous hysterectomy with bilateral oophorectomy
Raynaud's Disease
Trial design
Treatments tested in this trial
- Whole-Body Cryotherapy
Treatment groups
Locations
1Sponsors and collaborators
University of Edinburgh
Lead sponsor
NHS Lothian
Collaborator